Literature DB >> 19082374

Cytokine profile in Montenegro skin test of patients with localized cutaneous and mucocutaneous leishmaniasis.

Marcia Ferraz Nogueira1, Hiro Goto, Mírian Nacagami Sotto, Luiz Carlos Cucé.   

Abstract

American tegumentary leishmaniasis presents as two major clinical forms: localized cutaneous leishmaniasis (LCL) and mucocutaneous leishmaniasis (MCL). The immune response in leishmaniasis is efficiently evaluated by the response to Leishmania antigen through the Montenegro skin test (MST). Both LCL and MCL present positive response to MST, indicating that the patients present cell-mediated immunity against the parasite - Leishmania. In spite of the presence of immunity in MCL, this is not sufficient to stop disease progression and prevent resistance to treatment. In this study we demonstrated interleukin (IL) 2, 4, 5 and interferon (IFN) gamma expression in biopsies of MST of ten patients with American tegumentary leishmaniasis. The obtained results were compared between LCL (n = 5) and MCL (n = 5) patients. The MST of MCL patients displayed a higher expression of IL-2, IL-4 and IL-5, in comparison to LCL. There was no significant difference in IFN-gamma expression between groups. The obtained results suggest the role of IL-4 and IL-5 in the maintenance of the immunopathogenic mechanism of the destructive lesions that characterize MCL.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19082374     DOI: 10.1590/s0036-46652008000600004

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  4 in total

1.  Profiles of Local and Systemic Inflammation in the Outcome of Treatment of Human Cutaneous Leishmaniasis Caused by Leishmania (Viannia).

Authors:  Adriana Navas; Olga Fernández; Carolina Gallego-Marín; María Del Mar Castro; Mariana Rosales-Chilama; Julieth Murillo; Alexandra Cossio; Diane McMahon-Pratt; Nancy Gore Saravia; María Adelaida Gómez
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

2.  Mucocutaneous Leishmaniasis: clinical markers in presumptive diagnosis.

Authors:  João Luiz Cioglia Pereira Diniz; Manoel Otávio da Rocha Costa; Denise Utsch Gonçalves
Journal:  Braz J Otorhinolaryngol       Date:  2011-06

3.  Montenegro skin test and age of skin lesion as predictors of treatment failure in cutaneous leishmaniasis.

Authors:  Liliane de Fátima Antonio; Aline Fagundes; Raquel Vasconcellos Carvalhaes Oliveira; Priscila Garcia Pinto; Sandro Javier Bedoya-Pacheco; Erica de Camargo Ferreira e Vasconcellos; Maria Cláudia Valete-Rosalino; Marcelo Rosandiski Lyra; Sônia Regina Lambert Passos; Maria Inês Fernandes Pimentel; Armando de Oliveira Schubach
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Sep-Oct       Impact factor: 1.846

4.  IFN-γ Response Is Associated to Time Exposure Among Asymptomatic Immune Responders That Visited American Tegumentary Leishmaniasis Endemic Areas in Peru.

Authors:  Ivan Best; Angela Privat-Maldonado; María Cruz; Mirko Zimic; Rachel Bras-Gonçalves; Jean-Loup Lemesre; Jorge Arévalo
Journal:  Front Cell Infect Microbiol       Date:  2018-08-21       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.